The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals.
SARS-CoV-2
coronavirus
mathematical model
nosocomial transmission
Journal
Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623
Informations de publication
Date de publication:
19 07 2021
19 07 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
11
6
2021
Statut:
ppublish
Résumé
Nosocomial transmission of SARS-CoV-2 is a key concern, and evaluating the effect of testing and infection prevention and control strategies is essential for guiding policy in this area. Using a within-hospital SEIR transition model of SARS-CoV-2 in a typical English hospital, we estimate that between 9 March 2020 and 17 July 2020 approximately 20% of infections in inpatients, and 73% of infections in healthcare workers (HCWs) were due to nosocomial transmission. Model results suggest that placing suspected COVID-19 patients in single rooms or bays has the potential to reduce hospital-acquired infections in patients by up to 35%. Periodic testing of HCWs has a smaller effect on the number of hospital-acquired COVID-19 cases in patients, but reduces infection in HCWs by as much as 37% and results in only a small proportion of staff absences (approx. 0.3% per day). This is considerably less than the 20-25% of staff that have been reported to be absent from work owing to suspected COVID-19 and self-isolation. Model-based evaluations of interventions, informed by data collected so far, can help to inform policy as the pandemic progresses and help prevent transmission in the vulnerable hospital population. This article is part of the theme issue 'Modelling that shaped the early COVID-19 pandemic response in the UK'.
Identifiants
pubmed: 34053255
doi: 10.1098/rstb.2020.0268
pmc: PMC8165586
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200268Subventions
Organisme : Versus Arthritis
ID : 22294
Pays : United Kingdom
Références
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Elife. 2020 Aug 21;9:
pubmed: 32820721
Emerg Infect Dis. 2015 Nov;21(11):2022-8
pubmed: 26488116
J R Soc Interface. 2010 Jun 6;7(47):873-85
pubmed: 19892718
Sex Health. 2005;2(4):255-8
pubmed: 16402675
PLoS Comput Biol. 2013;9(2):e1002916
pubmed: 23468606
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Br Med Bull. 2009;92:33-42
pubmed: 19855103
Lancet Respir Med. 2020 Sep;8(9):885-894
pubmed: 32717210
J Infect Dis. 2018 Sep 22;218(9):1485-1489
pubmed: 29873767
Elife. 2020 Jun 19;9:
pubmed: 32558644
Clin Infect Dis. 2021 Nov 2;73(9):e3127-e3129
pubmed: 33570097
Palliat Med. 2008 Sep;22(6):702-10
pubmed: 18715968
J Infect. 2021 Nov;83(5):565-572
pubmed: 34474055
Nat Rev Microbiol. 2008 Jun;6(6):477-87
pubmed: 18533288
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Lancet Infect Dis. 2020 Dec;20(12):1381-1389
pubmed: 32822577
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
Genome Biol. 2014 Nov 18;15(11):538
pubmed: 25418119
JAMA Intern Med. 2019 Nov 01;179(11):1501-1506
pubmed: 31424489
Infect Control Hosp Epidemiol. 2007 Apr;28(4):412-7
pubmed: 17385146
Infect Control Hosp Epidemiol. 2016 Jun;37(6):680-4
pubmed: 27074865